Jpmorgan Chase & CO Bionano Genomics, Inc. Transaction History

Jpmorgan Chase & CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.57 - $1.16 $131,533 - $267,681	-230,760 Reduced 96.77%	7,699 $4,000
Q1 2023 May 18, 2023	BUY	$1.06 - $1.97 $242,964 - $451,547	229,212 Added 2478.77%	238,459 $264,000
Q1 2023 May 11, 2023	SELL	$1.06 - $1.97 $177,158 - $329,248	-167,131 Reduced 94.76%	9,247 $10,000
Q4 2022 Feb 13, 2023	BUY	$1.4 - $25.4 $21,739 - $394,411	15,528 Added 9.65%	176,378 $257,000
Q3 2022 Nov 14, 2022	BUY	$0.36 - $36.0 $1,238 - $123,876	3,441 Added 2.19%	160,850 $294,000
Q2 2022 Aug 11, 2022	SELL	$12.3 - $27.3 $765,330 - $1.7 Million	-62,222 Reduced 28.33%	157,409 $217,000
Q1 2022 May 11, 2022	BUY	$16.6 - $32.3 $589,847 - $1.15 Million	35,533 Added 19.3%	219,631 $567,000
Q4 2021 Feb 10, 2022	BUY	$29.9 - $61.2 $420,483 - $860,655	14,063 Added 8.27%	184,098 $551,000
Q3 2021 Nov 12, 2021	BUY	$51.4 - $68.2 $8.74 Million - $11.6 Million	170,035 New	170,035 $935,000

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $58M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.